MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. (Q41412869)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 January 2010
edit
Language Label Description Also known as
English
MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.
scientific article published on 26 January 2010

    Statements

    MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit